Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures
Tian Hua,Xiaoting Li,Lijie Wu,Christos Iliopoulos-Tsoutsouvas,Yuxia Wang,Meng Wu,Ling Shen,Christina A Brust,Spyros P Nikas,Feng Song,Xiyong Song,Shuguang Yuan,Qianqian Sun,Yiran Wu,Shan Jiang,Travis W Grim,Othman Benchama,Edward L Stahl,Nikolai Zvonok,Suwen Zhao,Laura M Bohn,Alexandros Makriyannis,Zhi-Jie Liu
DOI: https://doi.org/10.1016/j.cell.2020.01.008
IF: 64.5
2020-02-20
Cell
Abstract:Human endocannabinoid systems modulate multiple physiological processes mainly through the activation of cannabinoid receptors CB1 and CB2. Their high sequence similarity, low agonist selectivity, and lack of activation and G protein-coupling knowledge have hindered the development of therapeutic applications. Importantly, missing structural information has significantly held back the development of promising CB2-selective agonist drugs for treating inflammatory and neuropathic pain without the psychoactivity of CB1. Here, we report the cryoelectron microscopy structures of synthetic cannabinoid-bound CB2 and CB1 in complex with Gi, as well as agonist-bound CB2 crystal structure. Of important scientific and therapeutic benefit, our results reveal a diverse activation and signaling mechanism, the structural basis of CB2-selective agonists design, and the unexpected interaction of cholesterol with CB1, suggestive of its endogenous allosteric modulating role.